Blog
Facing the Challenge: How to Conduct Remote Cognitive Assessments
The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development. In this series, we’re sharing some of the ways VeraSci is addressing these...
read moreSelecting Outcome Assessments in Multiple Sclerosis
Multiple sclerosis is a complex disease that presents numerous challenges in selecting appropriate measurements for a given clinical trial. These challenges can include: Handling inflammation and relapses versus degeneration and progression A lack of...
read moreFacing the Challenge: Remote Motor Assessments
The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development. In this series, we’re sharing some of the ways VeraSci is addressing these challenges. With...
read moreUnprecedented Challenges Call for Exceptional Solutions
Facing the Challenge: Remote Assessments for Clinical Trials During the COVID-19 Pandemic The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development....
read moreeCOA for Clinical Trials: What Should It Cost?
Many sponsors and CROs aren’t sure what to expect when it comes to the cost of an Electronic Clinical Outcome Assessment (eCOA) platform, but the advantages of using eCOA are well documented. While upfront costs are a substantial consideration for sponsors and CROs,...
read moreCultural Adaptation is Not an Option: International Research Benefits from Localization
Scientific research has become an increasingly globalized effort. As more countries prioritize their research funding, international clinical studies have become the norm. Localization of study tools, cultural awareness, and accurate translations have become crucial...
read moreTranslating Traditions: Holidays Around the World
Translation alone is often not enough to ensure an accurate message; cultural differences can make it easy to misunderstand the intended meaning of a text. For this reason, VeraSci insists that cultural adaptation and localization are not an option when it comes to...
read moreA Novel MS Patient-Centered Assessment to Monitor Symptomatology
Recent findings from a National Multiple Sclerosis (MS) Study estimate that nearly 1 million people in the US are living with MS, a number that has more than doubled since it was last reported in 1975. We at VeraSci are committed to helping our clients drive therapies...
read moreVeraSci Celebrates International Women’s Day Through Women Leadership and Diversity
March 8th was International Women’s Day, a day that we at VeraSci celebrate the work of a group of remarkable women – women scientists. While Marie Curie usually dominates the women in science conversation, there are many other brilliant women scientists. Not only did...
read moreDA4S West Coast Wrap Up
VeraSci attended the 6th Annual Diversity Alliance for Science West Coast Conference, February 20th-21st in Laguna Beach, California. VeraSci is honored to participate in one of the leading organizations in the life science and healthcare industries which promotes the...
read more